'Orange Book' Changes? US FDA Soliciting Comments On TE Codes

 
• By Derrick Gingery
  
Generics
The FDA also seeks comments on the potential changes to 'Orange Book' patent listing practices. • Source: Shutterstock

More from US FDA

More from Agency Leadership